MENU
ROIV
AS OF
Feb 3 closing price
Price
$21.97
Change
+$5.85 (+36.29%)
Capitalization
15.29B
2 days until earnings call
Intraday BUY SELL Signals
+Compare
ROIV
Stock ticker: NASDAQ
AS OF
Feb 3 closing price
Price
$21.97
Change
+$5.85 (+36.29%)
Capitalization
15.29B

ROIV Roivant Sciences Ltd Forecast, Technical & Fundamental Analysis

Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients... Show more

ROIV
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
a Summary for ROIV with price predictions
Feb 03, 2026

ROIV sees MACD Histogram crosses below signal line

ROIV saw its Moving Average Convergence Divergence Histogram (MACD) turn negative on January 23, 2026. This is a bearish signal that suggests the stock could decline going forward. Tickeron's A.I.dvisor looked at 55 instances where the indicator turned negative. In of the 55 cases the stock moved lower in the days that followed. This puts the odds of a downward move at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The 10-day RSI Indicator for ROIV moved out of overbought territory on January 15, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 33 similar instances where the indicator moved out of overbought territory. In of the 33 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Momentum Indicator moved below the 0 level on January 28, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on ROIV as a result. In of 94 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ROIV declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

ROIV broke above its upper Bollinger Band on January 13, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Bullish Trend Analysis

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 4 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

ROIV moved above its 50-day moving average on February 02, 2026 date and that indicates a change from a downward trend to an upward trend.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where ROIV advanced for three days, in of 272 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 211 cases where ROIV Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. ROIV’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock slightly better than average.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.504) is normal, around the industry mean (27.519). P/E Ratio (1.966) is within average values for comparable stocks, (51.491). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.893). Dividend Yield (0.000) settles around the average of (0.043) among similar stocks. P/S Ratio (769.231) is also within normal values, averaging (331.843).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

View a ticker or compare two or three
ROIV
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published Earnings

ROIV is expected to report earnings to rise 79.76% to -30 cents per share on February 06

Roivant Sciences Ltd ROIV Stock Earnings Reports
Q4'25
Est.
$-0.31
Q3'25
Beat
by $0.15
Q2'25
Missed
by $0.08
Q1'25
Missed
by $0.03
Q4'24
Beat
by $0.48
The last earnings report on November 10 showed earnings per share of -17 cents, beating the estimate of -31 cents. With 4.26M shares outstanding, the current market capitalization sits at 15.29B.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
50 Broadway
Phone
+44 2074003347
Employees
904
Web
N/A
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
PBTP26.03N/A
+0.02%
Invesco 0-5 Yr US TIPS ETF
QBUL23.73-0.06
-0.25%
TrueShares Quarterly Bull Hedge ETF
USPX60.33-0.53
-0.87%
Franklin US Equity Index ETF
MSLC54.84-0.51
-0.91%
Morgan Stanley Pathway Large Cap Eq ETF
ESPO97.98-2.75
-2.73%
VanEck Vdo Gaming and eSprts ETF

ROIV and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, ROIV has been loosely correlated with IMVT. These tickers have moved in lockstep 59% of the time. This A.I.-generated data suggests there is some statistical probability that if ROIV jumps, then IMVT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ROIV
1D Price
Change %
ROIV100%
+1.48%
IMVT - ROIV
59%
Loosely correlated
+0.31%
NUVL - ROIV
50%
Loosely correlated
+2.00%
KYMR - ROIV
49%
Loosely correlated
+4.03%
RVMD - ROIV
48%
Loosely correlated
+0.22%
CRNX - ROIV
48%
Loosely correlated
-1.18%
More